ASNS: Actelis Networks, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 5.50
Enterprise Value ($M) 4.31
Book Value ($M) 2.76
Book Value / Share 0.32
Price / Book 1.99
NCAV ($M) 1.44
NCAV / Share 0.17
Price / NCAV 3.83

Profitability (mra)
Return on Invested Capital (ROIC) -1.07
Return on Assets (ROA) -0.42
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.97
Current Ratio 1.51

Balance Sheet (mrq) ($M)
Current Assets 6.90
Assets 8.22
Liabilities 5.47
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.76
Operating Income -3.92
Net Income -4.37
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -6.55
Cash from Investing 0.20
Cash from Financing 3.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
12-26 13G Sternheim Eliezer 6.30
11-14 13G/A Armistice Capital, Llc 4.99 4.84

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 11,591 36,794 31.50
2025-04-16 4,057 38,912 10.43
2025-04-15 7,135 41,235 17.30

(click for more detail)

Similar Companies
APRE – Aprea Therapeutics, Inc. APVO – Aptevo Therapeutics Inc.
ARTL – Artelo Biosciences, Inc. ASRT – Assertio Holdings, Inc.
ATHA – Athira Pharma, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.